Federal contract award
HHSN27500007
IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIALCONTRACT # HHSN275201300024I/HHSN27500007
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541711 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | HHSN275201300024I |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $12.0M |
| Current contract value | $12.0M |
| Potential contract value / ceiling | $12.0M |
| Start date | Sep 14, 2015 |
| Current end date | Dec 31, 2026 |
| Potential end date | Dec 31, 2026 |
| Latest award activity | Aug 6, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 6, 2026 | P00009 | $224.3K | NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE |
| Dec 15, 2025 | P00008 | $0 | NICHD: R&D: CLINICAL TREATMENT OF NESTORONE GEL AND TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE |
| Sep 25, 2024 | P00007 | $301.9K | CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL CONTRACT HHSN275201300024I HHSN27500007 |
| Sep 18, 2024 | P00006 | $0 | CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL CONTRACT HHSN275201300024I HHSN27500007 |
| Mar 3, 2023 | P00005 | $2.8M | CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL CONTRACT #HHSN275201300024I/HHSN27500007 |
| May 4, 2022 | P00004 | $2.3M | CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIAL CONTRACT #HHSN275201300024I/HHSN27500007 |
| Sep 9, 2020 | P00003 | $0 | CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIALCONTRACT #HHSN275201300024I/HHSN27500007 |
| May 19, 2020 | P00002 | $3.3M | CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIALCONTRACT #HHSN275201300024I/HHSN27500007 |
| Oct 4, 2018 | P00001 | $0 | CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIALCONTRACT #HHSN275201300024I/HHSN27500007 |
| Sep 14, 2015 | 0 | $3.1M | IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIAL NETWORK - MALE SITES - CONTRACEPTIVE EFFICACY CLINICAL TRIALCONTRACT # HHSN275201300024I/HHSN27500007 |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
85/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 85/100. Available recorded signals: 80 points.
- Contract end 2026-12-31 (60 days from calculation)
- +35 points
- 5 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2026-08-06
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.